drugset / Trial / NCT01666041

Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate

NCT01666041

Phase 4 Completed 120 enrolled Gachon University Gil Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators hypothesize that fenofibrate/omega will improve insulin resistance compared with fenofibrate

Timeline

Start
2012-01
Primary completion
2013-02
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenofibrate Small molecule

Indications